Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

VidaMed completes IPO; nets over $20 million

Executive Summary

VidaMed (devices for the treatment of benign prostatic hyperplasia) has netted about $18 million in an IPO of 3.1 million shares at $6.50 per share. When the offering was registered in May, the company intended to sell 2.5 million share at $10 each.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies